Align Tech's Q3 Net Income Halves Amid Rising Costs, Restructuring
Ticker: ALGN · Form: 10-Q · Filed: 2025-11-05T00:00:00.000Z
Sentiment: bearish
Topics: Dental Technology, Clear Aligners, Earnings Miss, Restructuring, Profitability Decline, Stock Repurchases, Medical Devices
Related Tickers: ALGN, NVST, XRAY
TL;DR
**Align's Q3 earnings are a red flag, with net income cut in half and restructuring charges signaling deeper operational issues than the slight revenue bump suggests.**
AI Summary
ALIGN TECHNOLOGY, INC. (ALGN) reported a mixed financial performance for the three and nine months ended September 30, 2025. For the three months, net revenues increased slightly to $995.7 million from $977.9 million in the prior year, a 1.8% rise. However, net income significantly decreased by 51.0% to $56.8 million from $116.0 million, primarily due to a substantial increase in cost of net revenues to $356.5 million from $296.1 million and a new restructuring charge of $31.8 million. Diluted EPS fell to $0.78 from $1.55. For the nine months, net revenues saw a slight decline to $2,987.4 million from $3,003.8 million, a 0.5% decrease. Net income for the nine months also decreased by 13.5% to $274.6 million from $317.6 million, with diluted EPS dropping to $3.77 from $4.23. The company incurred $31.8 million in restructuring and other charges during the nine-month period, which was not present in the prior year. Cash and cash equivalents decreased to $1,004.6 million as of September 30, 2025, from $1,043.9 million at December 31, 2024, largely due to $368.7 million in common stock repurchases. An impairment loss of $23.1 million on assets held for sale was also recognized in the nine months ended September 30, 2025.
Why It Matters
Align Technology's significant drop in net income and diluted EPS, despite a slight revenue increase, signals potential margin pressures and operational inefficiencies that investors should scrutinize. The $31.8 million restructuring charge and increased cost of net revenues suggest the company is undergoing strategic shifts or facing higher production expenses, which could impact its competitive position against rivals like Envista Holdings (NVST) or Dentsply Sirona (XRAY). For employees, restructuring charges often imply workforce adjustments, creating uncertainty. Customers might see price adjustments or changes in product offerings as the company optimizes. The broader dental clear aligner market, while growing, is becoming more competitive, and Align's ability to maintain profitability will be key to its long-term market leadership.
Risk Assessment
Risk Level: high — The risk level is high due to a 51.0% decrease in net income for the three months ended September 30, 2025, to $56.8 million from $116.0 million in the prior year. This decline is exacerbated by a $31.8 million restructuring charge and a $23.1 million impairment loss on assets held for sale, indicating significant operational challenges and asset write-downs.
Analyst Insight
Investors should exercise caution and consider a 'hold' or 'reduce' position on ALGN. The substantial decline in net income and the new restructuring charges warrant a deeper dive into the company's operational efficiency and future growth strategy before making new investments.
Financial Highlights
- revenue
- $995.7M
- operating Margin
- 9.7%
- net Income
- $56.8M
- eps
- $0.78
- gross Margin
- 64.2%
- cash Position
- $1,004.6M
- revenue Growth
- +1.8%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Net Revenues | $995.7M | +1.8% |
| Total Net Revenues | $2,987.4M | -0.5% |
Key Numbers
- $995.7M — Net Revenues (Q3 2025) (Increased 1.8% from $977.9M in Q3 2024)
- $56.8M — Net Income (Q3 2025) (Decreased 51.0% from $116.0M in Q3 2024)
- $0.78 — Diluted EPS (Q3 2025) (Decreased from $1.55 in Q3 2024)
- $31.8M — Restructuring Charges (Q3 2025) (New charge, not present in Q3 2024)
- $356.5M — Cost of Net Revenues (Q3 2025) (Increased from $296.1M in Q3 2024)
- $2,987.4M — Net Revenues (9 Months 2025) (Decreased 0.5% from $3,003.8M in 9 Months 2024)
- $274.6M — Net Income (9 Months 2025) (Decreased 13.5% from $317.6M in 9 Months 2024)
- $3.77 — Diluted EPS (9 Months 2025) (Decreased from $4.23 in 9 Months 2024)
- $368.7M — Common Stock Repurchases (9 Months 2025) (Increased from $150.0M in 9 Months 2024)
- $23.1M — Impairment Loss on Assets Held for Sale (9 Months 2025) (New loss, not present in 9 Months 2024)
Key Players & Entities
- ALIGN TECHNOLOGY, INC. (company) — registrant
- SEC (regulator) — Securities and Exchange Commission
- $995,692 (dollar_amount) — net revenues for three months ended September 30, 2025
- $977,872 (dollar_amount) — net revenues for three months ended September 30, 2024
- $56,753 (dollar_amount) — net income for three months ended September 30, 2025
- $115,963 (dollar_amount) — net income for three months ended September 30, 2024
- $31,827 (dollar_amount) — restructuring and other charges for three and nine months ended September 30, 2025
- $0.78 (dollar_amount) — diluted net income per share for three months ended September 30, 2025
- $1.55 (dollar_amount) — diluted net income per share for three months ended September 30, 2024
- $368,691 (dollar_amount) — common stock repurchases for nine months ended September 30, 2025
FAQ
What were Align Technology's net revenues for the three months ended September 30, 2025?
Align Technology's net revenues for the three months ended September 30, 2025, were $995,692 thousand, a slight increase from $977,872 thousand in the same period of 2024.
How did Align Technology's net income change in Q3 2025 compared to Q3 2024?
Align Technology's net income significantly decreased by 51.0% to $56,753 thousand for the three months ended September 30, 2025, from $115,963 thousand in the prior year's third quarter.
What was the diluted net income per share for ALGN in the third quarter of 2025?
The diluted net income per share for ALGN in the third quarter of 2025 was $0.78, a decrease from $1.55 reported for the same period in 2024.
Did Align Technology incur any restructuring charges in the nine months ended September 30, 2025?
Yes, Align Technology incurred $31,827 thousand in restructuring and other charges for both the three and nine months ended September 30, 2025, which was not present in the comparable periods of 2024.
What was the total amount of common stock repurchases by Align Technology in the nine months ended September 30, 2025?
Align Technology repurchased common stock totaling $368,691 thousand, net of excise tax, during the nine months ended September 30, 2025.
How much cash and cash equivalents did Align Technology have as of September 30, 2025?
As of September 30, 2025, Align Technology had $1,004,589 thousand in cash and cash equivalents, a decrease from $1,043,887 thousand at December 31, 2024.
What was the impact of the impairment loss on assets held for sale for Align Technology?
Align Technology recognized an impairment loss of $23,142 thousand on assets held for sale during the nine months ended September 30, 2025, contributing to the decrease in net income.
What are the key risks highlighted in Align Technology's 10-Q filing?
Key risks include reliance on sole suppliers for certain inventory and a limited number of hardware manufacturers, which could materially and adversely impact future operating results if supply requirements are not met.
What accounting pronouncements did Align Technology adopt recently?
Align Technology adopted ASU 2023-07, "Improvements to Reportable Segment Disclosures," in the fiscal year ended December 31, 2024, which enhances disclosures about significant segment expenses.
How did operating expenses change for Align Technology in Q3 2025?
Total operating expenses for Align Technology increased to $542,903 thousand for the three months ended September 30, 2025, from $519,476 thousand in the prior year, primarily due to the $31,827 thousand in restructuring and other charges.
Risk Factors
- Increased Cost of Revenues [high — operational]: Cost of net revenues increased significantly by $60.4 million (20.4%) to $356.5 million for Q3 2025 from $296.1 million in Q3 2024. For the nine months, it rose by $58.4 million (6.5%) to $959.9 million from $901.6 million. This directly impacted gross profit and net income.
- Restructuring and Other Charges [medium — operational]: The company incurred new restructuring and other charges of $31.8 million in Q3 2025 and for the nine months ended September 30, 2025. These charges were not present in the prior year periods and negatively impacted net income.
- Stock Repurchases Impacting Cash [medium — financial]: Cash and cash equivalents decreased by $39.3 million to $1,004.6 million as of September 30, 2025, from $1,043.9 million at December 31, 2024. This was largely due to $368.7 million in common stock repurchases during the nine-month period.
- Impairment Loss on Assets Held for Sale [low — financial]: An impairment loss of $23.1 million on assets held for sale was recognized in the nine months ended September 30, 2025. This represents a new charge impacting profitability for the period.
- Legal Settlement Costs [low — regulatory]: While legal settlement costs decreased significantly from $31.2 million in the nine months of 2024 to $4.2 million in the nine months of 2025, the presence of such charges highlights ongoing legal risks.
Industry Context
Align Technology operates in the dental and orthodontic market, specifically focusing on clear aligners and related digital solutions. The industry is characterized by increasing adoption of digital dentistry, competition from traditional orthodontics and other clear aligner providers, and evolving consumer demand for aesthetic and convenient treatment options.
Regulatory Implications
The company faces regulatory scrutiny related to medical devices and healthcare practices in various jurisdictions. While this filing doesn't detail new regulatory actions, ongoing compliance with FDA, international health authorities, and data privacy regulations (like HIPAA) remains critical. Legal settlement costs, though reduced, highlight potential litigation risks.
What Investors Should Do
- [object Object]
- [object Object]
- [object Object]
- [object Object]
Key Dates
- 2025-09-30: End of Q3 2025 and Nine Months Reporting Period — Marks the period for which the financial results, including revenue, net income, and EPS changes, are reported, showing a decline in profitability despite slight revenue growth in Q3.
- 2025-12-31: End of Fiscal Year 2024 — Provides the comparative balance sheet data for cash and cash equivalents, against which the September 30, 2025 position is measured.
Glossary
- Cost of net revenues
- The direct costs associated with producing and delivering the company's products and services. (A significant increase in this cost for Q3 2025 directly reduced gross profit and net income, indicating potential supply chain pressures or increased production expenses.)
- Restructuring and other charges
- Costs incurred by a company related to significant reorganizations, such as layoffs, facility closures, or business divestitures. (The introduction of $31.8 million in these charges for 2025 negatively impacted net income, representing a new expense not present in the prior year.)
- Impairment loss on assets held for sale
- A reduction in the carrying value of assets that are classified as held for sale when their fair value is less than their book value. (The $23.1 million loss recognized in 2025 indicates a write-down of assets intended for disposal, impacting the company's overall financial performance.)
- Common stock repurchases
- The company's buying back its own shares from the open market. (Significant repurchases totaling $368.7 million in the first nine months of 2025 contributed to a decrease in cash and cash equivalents.)
Year-Over-Year Comparison
Compared to the prior year, Align Technology Inc. reported a mixed performance. Net revenues for Q3 2025 saw a modest increase of 1.8% to $995.7 million, but net income plummeted by 51.0% to $56.8 million due to a significant rise in the cost of net revenues and new restructuring charges. For the first nine months of 2025, net revenues slightly decreased by 0.5% to $2,987.4 million, while net income fell 13.5% to $274.6 million. Cash reserves decreased, largely driven by substantial stock repurchases, and an impairment loss on assets held for sale was also recorded.
Filing Stats: 4,534 words · 18 min read · ~15 pages · Grade level 16.2 · Accepted 2025-11-05 16:06:43
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value ALGN The NASDAQ Stock Market
Filing Documents
- algn-20250930.htm (10-Q) — 1674KB
- algn-20250930xex311.htm (EX-31.1) — 10KB
- algn-20250930xex312.htm (EX-31.2) — 10KB
- algn-20250930xex321.htm (EX-32.1) — 9KB
- 0001097149-25-000079.txt ( ) — 8753KB
- algn-20250930.xsd (EX-101.SCH) — 49KB
- algn-20250930_cal.xml (EX-101.CAL) — 80KB
- algn-20250930_def.xml (EX-101.DEF) — 259KB
- algn-20250930_lab.xml (EX-101.LAB) — 662KB
- algn-20250930_pre.xml (EX-101.PRE) — 484KB
- algn-20250930_htm.xml (XML) — 1436KB
F INANCIAL INFORMATION
PART I F INANCIAL INFORMATION 3
F inancial S tatements (U naudited )
Item 1. F inancial S tatements (U naudited ): 3 Condensed Consolidated Statements of Operations 3 C ondensed C onsolidated S tatements of C omprehensive Income 4 Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 28
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 39
Controls and Procedures
Item 4. Controls and Procedures 40
O THER INFORMATION
PART II O THER INFORMATION 40
Legal Proceedings
Item 1. Legal Proceedings 40
Risk Factors
Item 1A. Risk Factors 40
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 55
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 55
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 55
Other Information
Item 5. Other Information 55
Exhibits
Item 6. Exhibits 57
Signatures
Signatures 58 Invisalign, Align, the Invisalign logo, ClinCheck, Invisalign Assist, Invisalign First, Invisalign Go, the Invisalign sonic logo, Vivera, SmartForce, SmartTrack, SmartStage, SmileView, iTero, iTero Element, iTero Lumina, Orthocad, exocad, Align Digital Platform, Align Oral Health Suite, Invisalign Smile Architect, iTero exocad Connector, exocad Dental CAD, and Cubicure, among others, are trademarks and/or service marks of Align Technology, Inc. or one of its subsidiaries or affiliated companies and may be registered in the United States and/or other countries. 2 Table of Contents
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements. ALIGN TECHNOLOGY, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net revenues $ 995,692 $ 977,872 $ 2,987,403 $ 3,003,793 Cost of net revenues 356,491 296,098 959,977 901,575 Gross profit 639,201 681,774 2,027,426 2,102,218 Operating expenses: Selling, general and administrative 417,800 434,138 1,314,115 1,338,222 Research and development 93,276 85,272 286,875 269,324 Restructuring and other charges 31,827 — 31,827 — Legal settlement loss — 66 4,178 31,193 Total operating expenses 542,903 519,476 1,636,995 1,638,739 Income from operations 96,298 162,298 390,431 463,479 Interest income and other income (expense), net: Interest income 3,249 4,003 11,424 11,696 Other income (expense), net ( 4,813 ) ( 371 ) 6,837 ( 6,993 ) Total interest income and other income (expense), net ( 1,564 ) 3,632 18,261 4,703 Net income before provision for income taxes 94,734 165,930 408,692 468,182 Provision for income taxes 37,981 49,967 134,101 150,627 Net income $ 56,753 $ 115,963 $ 274,591 $ 317,555 Net income per share: Basic $ 0.78 $ 1.55 $ 3.77 $ 4.23 Diluted $ 0.78 $ 1.55 $ 3.77 $ 4.23 Shares used in computing net income per share: Basic 72,377 74,736 72,831 75,031 Diluted 72,419 74,757 72,880 75,149 The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements. 3 Table of Contents ALIGN TECHNOLOGY, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (in thousands) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net income $ 56,753 $ 115,963 $ 274,591 $ 317,555 Other comprehensive income: Change in foreign currency translation adjustment, net of tax 4,185 10,713 59,394 14,140 Change in unrealized gains (losses) on investments, net of tax — 159 — 605 Other